Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino
I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado
{"title":"Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino","authors":"I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado","doi":"10.1007/BF03320878","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Spanish Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03320878","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
